AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Femasys Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG004M23R72
1.50▼ 0.06 (-3.85%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.56
Day's Range
1.46 – 1.59
52-Week Range
0.29 – 6.29
Volume
126.1K
Avg Volume
91.6K
Share Statistics
Shares Outstanding
Employees
54
Exchange
XNAS
Listed
2021-06-18
Share count as of August 13, 2026

Femasys Inc. Common Stock (FEMY) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Femasys Inc. Common Stock (FEMY)
What is Femasys Inc. Common Stock's Market Cap?
Femasys Inc. Common Stock's Market Cap is $12.6M, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's Enterprise Value?
Femasys Inc. Common Stock's Enterprise Value is $11.1M, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's Price / Sales?
Femasys Inc. Common Stock's Price / Sales is 5.5×, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's EV / Revenue?
Femasys Inc. Common Stock's EV / Revenue is 4.8×, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's EV / EBITDA?
Femasys Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's Revenue (TTM)?
Femasys Inc. Common Stock's Revenue (TTM) is $2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's Net Income (TTM)?
Femasys Inc. Common Stock's Net Income (TTM) is -$11.8M, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's EBITDA?
Femasys Inc. Common Stock's EBITDA is -$17.2M, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's Diluted EPS (TTM)?
Femasys Inc. Common Stock's Diluted EPS (TTM) is -1.41, based on as-reported figures from SEC (XBRL) filings.
What is Femasys Inc. Common Stock's EBITDA Margin?
Femasys Inc. Common Stock's EBITDA Margin is -749.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · FEMYAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Sales
YoY growth-18.9%+24.5%+39.9%+31.4%
Cost of sales (excluding depreciation expense)
Operating expenses:
Research and development
Sales and marketing
General and administrative
Depreciation and amortization
Total operating expenses
% of revenue1583.7%1056.7%631.1%560.6%
Loss from operations
% of revenue-1526.7%-994.0%-568.3%-500.9%
Other income (expense):
Interest income
Change in fair value of conversion option liability——
Change in fair value of warrants liabilities——
Interest expense
Other expense—
Total other income (expense), net
Loss before income taxes
Income tax expense (benefit)
Net loss
% of revenue-1346.8%199.1%-485.7%-575.1%
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Basic loss per share (in Dollars per share)
Diluted loss per share (in Dollars per share)